TG Therapeutics Announces Long-term Follow-up Data from the Phase 2 Trial of Ublituximab in Patients with Multiple Sclerosis
MediciNova Announces MN-166 (ibudilast) Demonstrated a 26% Reduction in Confirmed Disability Progression
pharmaceutical investing Adamas Announces Publication of ADS-5102 Phase 2 Clinical Trial Results in Multiple Sclerosis Journal
pharmaceutical investing Corbus Gets Patent Covering Use of Anabasum for the Treatment of Rare Fibrotic Diseases
cannabis investing Phase 1 Clinical Trial Results Using Satipharm Capsules Published in International Medical Journal
pharmaceutical investing Adamas to Present New ADS-5102 Data from Phase 2 Trial in Walking Impairment Associated with Multiple Sclerosis
Blue Lagoon Announces Commissioning of MBBR Water Treatment System and Start of Underground Operations at Dome Mountain
Sranan Gold Announces Participation in Upcoming Capital Event Muskoka Conference and Munich Mining Conference
Kobo Resources Closes Second and Final Tranche of the Upsized Non-Brokered Private Placement for Gross Proceeds of Over $3.96Â Million
